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ABSTRACT
Objectives: This study aimed to characterise the
epidemiology of Chlamydia trachomatis (CT) and
Neisseria gonorrhoeae (NG) infections among men
who have sex with men (MSM) and transgender
women (TW) in Lima, Peru.
Setting: Cross-sectional study in Lima, Peru.
Participants: We recruited a group of 510 MSM and
208 TW for a subsequent community-based
randomised controlled trial. The presence of CT and
NG were evaluated using Aptima Combo2 in
pharyngeal and anal swabs. We also explored
correlates of these infections. Primary and secondary
outcome measures: Study end points included overall
prevalence of C. trachomatis and N. gonorrhoeae in
anal and pharyngeal sites.
Results: Overall prevalence of CT was 19% (95% CI
16.1% to 22.1%) and 4.8% (95% CI 3.3% to 6.6%) in
anal and pharyngeal sites, respectively, while
prevalence of NG was 9.6% (95% CI 7.5% to 12.0%)
and 6.5% (95% CI 4.8% to 8.5%) in anal and
pharyngeal sites, respectively.
Conclusions: The prevalence of each infection
declined significantly among participants older than
34 years (p<0.05). Efforts towards prevention and
treatment of extraurogenital chlamydial and gonococcal
infections in high-risk populations like MSM and TW in
Lima, Peru, are warranted.
Trial registration number: NCT00670163; Results.
INTRODUCTION
The most common curable genital sexually
transmitted infections (STI) worldwide are
those caused by Chlamydia trachomatis (CT)
and Neisseria gonorrhoeae (NG).1 They remain
a major public health challenge because
of their high prevalence and incidence,
especially among high-risk populations such
as men who have sex with men (MSM) and
transgender women (TW).2 3 Simultaneous
testing for both bacteria is highly recom-
mended and many current diagnostic
approaches combine the detection of both
agents since coinfection is common.4 5
With regard to CT and NG infections in
extragenital sites, their transmission from the
urogenital tract of one individual to the oro-
pharynx of another and vice versa has been
previously reported.6–8 Common sexual prac-
tices among MSM and TW such as fellatio,
anilingus, and both receptive and insertive
condomless anal intercourse can facilitate
CT and NG infections in exposed anatomical
sites. These facts highlight the importance
and complexities of the transmission of these
bacteria given the potential of the anorectum
and oropharynx to be infected or colonised,
and then to serve as silent reservoirs and new
Strengths and limitations of this study
▪ First study in Latin America to describe the
prevalence of non-genital infections in high-risk
men who have sex with men and transgender
populations.
▪ Comprehensive assessment of anal and pharyn-
geal Chlamydia trachomatis and Neisseria gonor-
rhoeae infections.
▪ Ethnographic sampling might preclude generalis-
ability of our findings to populations outside the
geographic areas under study.
▪ Oral sex was accessed in-depth; therefore, it is
not possible to link specific oral sex practices
and pharyngeal infections.
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sources of infections. However, many public health pro-
grammes in low and middle income countries, such as
Peru, still do not routinely screen for NG and CT in ano-
rectal and pharyngeal sites.5 9 10
The importance and potential impact of screening for
CT and NG in non-genital sites for both high-risk men
and women has been shown in several previous
studies.11 12 CT and NG infections in the oropharynx
and/or the anorectum are much more frequent among
MSM and TW than in heterosexual men.6 13–17 The
inclusion of CT and NG screening in some STI pro-
grammes at public STI clinics worldwide has showed a
significant increase in their detection, especially when
testing is targeted and based on reported sexual prac-
tices and STI history in these high-risk
populations.6 10 18
Our study aimed to characterise the epidemiology of
CT and NG infections among MSM and TW in Lima,
Peru.
METHODS
Study design, study population and setting
We analysed the baseline data of the ‘Comunidades
Positivas and Enhanced Partner Therapy Trial’
(ClinicalTrials.gov identifier: NCT00670163) collected
during 2008–2009 for a larger clinical trial which was
implemented in Lima, Peru, until 2012. This time frame
included planning, implementation and data analysis.
We recruited 718 participants who were 18–45-years-old,
born biologically male, who lived and/or socialised in
the study neighbourhoods, had anal or oral sex with
other men in the previous 12 months, and expressed
sexual preference for men. HIV status was not consid-
ered for enrolment purposes. Recruitment used a
snowball-like, peer-based referral approach in sites previ-
ously identified by ethnographic methods. This sample
size was defined a priori to meet the aims of the original
trial. Among the trial participants, 701 agreed to provide
self-collected anal swabs and 712 agreed to provide
technician-assisted pharyngeal swabs for screening. We
offered free treatment to all participants resulting with a
positive test for CT and/or NG according to the
Peruvian STI Management Guidelines (azithromycin,
1.0 g single dose orally for CT; cefixime, 400 mg single
dose orally for NG).19
Data collection
Mobile study teams went to each study neighbourhood
for 1–2 weeks to implement all study procedures using
temporary offices. Once the participant volunteered and
consented in written to participate in the study, they
were asked to respond to a questionnaire using a
Computer-Assisted Personal Interview (CAPI) system.20
The questionnaire collected information on demo-
graphic characteristics, general health and healthcare-
seeking behaviour, exposure to HIV/STI prevention
messages, HIV testing history, sexual risk behaviours and
substance use, and took approximately 60 min to com-
plete. After completing the questionnaire, all partici-
pants went through pretest counselling for STIs,
including HIV infection, with a trained counsellor
according to the Peruvian STI Management
guidelines.19
Laboratory procedures
We trained all participants to self-collect anal swabs, using
pictures and mirrors for guidance. Trained technicians
collected pharyngeal swabs by swabbing the tonsils. We
initially stored all collected samples in Aptima collection
tubes and then transported them to our laboratory facil-
ities in Lima where nucleic acid amplification testing
(NAAT) was performed. Specifically, the detection of CT
and/or NG infections was performed by means of a
Transcription Mediated Amplification (TMA) with the
Aptima Combo2 CT/NG test (Gen Probe Incorporated,
San Diego, California, USA) following the manufacturer’s
directions. NAAT technology is well known for being
highly sensitive and specific.15 18 21 22 The results were
given to the participants within 2 weeks of sample collec-
tion, along with post-test counselling and treatment, as
necessary, according to the Peruvian STI Management
Guidelines.19 Laboratory quality assurance was per-
formed on a randomly selected 10% of the samples and
conducted by the Laboratory of the San Francisco
Department of Public Health in California.
Variables and statistical analysis
Outcomes: The four outcome variables of interest for this
analysis were anorectal chlamydiasis, anorectal gonor-
rhoea, oropharyngeal chlamydiasis and oropharyngeal
gonorrhoea. We calculated their prevalences and 95%
CIs overall and for each of the three self-reported sexual
and gender identity subgroups (gay/homosexual,
male-to-female transgender women and bisexual/het-
erosexual). Composite outcomes for any infection and
concomitant coinfection at each anatomical site were
also calculated. The concomitant coinfection outcome
was generated in order to gain statistical power for later
modelling analysis, especially for the oral infection out-
comes given their very low absolute numbers.
Correlates: The following variables were used to
describe the study population and analysed to explore
their associations with the outcome variables: age, age at
sexual debut and number of sexual partners over the
past 6 months (given their distribution departure from
normality, these were re-categorised in tertiles), educa-
tional attainment, self-reported sexual/gender identity,
preferred role during anal sex, engagement in condom-
less anal intercourse, engagement in oral sex (without
differentiation if giving or receiving) and ever engaging
in compensated sex. Oral sex and condomless anal inter-
course were summary binary variables constructed from
responses provided by participants when asked for spe-
cific sexual behaviours with up to three most recent
sexual partners in the past 6 months.
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Table 1 Overall study population characteristics and their bivariate associations with anal and pharyngeal infections caused by Chlamydia trachomatis and Neisseria gonorrhoeae among 718 MSM/
TW participants in Lima, Peru, 2008–2009
Characteristics
Total
enrolled
(N=718)
n (%)
Provided anal swabs (N=701) Provided throat swabs (N=712)
Chlamydia trachomatis Neisseria gonorrhoeae Chlamydia trachomatis Neisseria gonorrhoeae
Positive=133
n (%)
Negative=568
n (%)
Positive=67
n (%)
Negative=634
n (%)
Positive=34
n (%)
Negative=678
n (%)
Positive=46
n (%)
Negative=666
n (%)
Demographic characteristics
Age (years)
Median (IQR) 29 (23–35) 26 (22–30) 29 (24–36) <0.05 24 (21–29) 29 (23–36) <0.05 25 (22–29) 29 (23–36) <0.05 25 (23–29) 29 (23–36) <0.05
Tertile 1: 18–25 261 (36.4) 61 (24.1) 192 (75.9) 37 (14.6) 216 (85.4) 18 (7.0) 241 (93.0) 24 (9.3) 235 (90.7)
Tertile 2: 26–33 242 (33.7) 50 (21.2) 186 (78.8) <0.05 25 (10.6) 211 (89.4) <0.05 12 (5.0) 227 (95.0) 0.05 16 (6.7) 223 (93.3) <0.05
Tertile 3: 34–45 215 (29.9) 22 (10.4) 190 (89.6) 5 (2.4) 207 (97.6) 4 (1.9) 210 (98.1) 6 (2.8) 208 (97.2)
Educational attainment
At least some beyond HS 204 (28.4) 42 (21.1) 157 (78.9) 19 (9.6) 180 (90.4) 9 (4.5) 192 (95.5) 15 (7.5) 186 (92.5)
Full/partially attended HS 448 (62.4) 83 (19.0) 353 (81.0) 0.27 38 (8.7) 398 (91.3) 0.25 22 (4.9) 423 (95.1) 0.96 24 (5.4) 421 (94.6) 0.22
Elementary or none 66 (9.2) 8 (12.1) 58 (87.9) 10 (15.2) 56 (84.8) 3 (4.6) 63 (95.4) 7 (10.6) 59 (89.4)
Self-reported sexual identity
Gay/homosexual 465 (64.8) 87 (19.2) 366 (80.8) 39 (8.6) 414 (91.4) 19 (4.1) 441 (95.9) 25 (5.4) 435 (94.6)
Transgender women 208 (29.0) 41 (20.1) 163 (79.9) 0.40 25 (12.3) 179 (87.7) 0.28 14 (6.7) 194 (93.3) 0.25 20 (9.6) 188 (90.4) 0.06
Bisexual/heterosexual 45 (6.2) 5 (11.4) 39 (88.6) 3 (6.8) 41 (93.2) 1 (2.3) 43 (97.7) 1 (2.3) 43 (97.7)
Sexual characteristics
Sexual role during anal sex
Pasivo 485 (67.5) 89 (18.8) 384 (81.2) 45 (9.5) 428 (90.5) 23 (4.8) 458 (95.2) 30 (6.2) 451 (93.8)
Moderno 188 (26.2) 41 (22.2) 144 (77.8) 0.07 20 (10.8) 165 (89.2) 0.46 9 (4.8) 177 (95.2) 0.99 13 (7.0) 173 (93.0) 0.94
Activo 45 (6.3) 3 (7.0) 40 (93.0) 2 (4.7) 41 (95.3) 2 (4.4) 43 (95.6) 3 (6.7) 42 (93.3)
Sexual debut
Median (IQR) 14 (12–16) 14 (12–16) 14 (12–16) 0.12 14 (12–15) 14 (12–16) 0.24 13 (12–15) 14 (12–16) 0.15 14 (13–17) 14 (12–16) 0.50
Tertile 1: 13 or younger 294 (41.0) 61 (21.0) 229 (79.0) 28 (9.7) 262 (90.3) 18 (6.2) 274 (93.8) 15 (5.1) 277 (94.9)
Tertile 2: 14–15 188 (26.2) 38 (20.8) 145 (79.2) 0.16 24 (13.1) 159 (86.9) 0.08 9 (4.8) 179 (95.2) 0.25 14 (7.5) 174 (92.5) 0.49
Tertile 3: 16 or older 236 (32.8) 34 (14.9) 194 (85.1) 15 (6.6) 213 (93.4) 7 (3.0) 225 (97.0) 17 (7.3) 215 (92.7)
Sexual partners over the past 6 months*
Median (IQR) 5 (2–15) 5 (2–15) 4 (2–15) 0.67 7 (4–30) 4 (2–15) <0.05 7 (3–30) 4 (2–15) <0.05 6 (2–18) 4 (2–15) 0.56
1 partner 111 (16.1) 14 (12.8) 95 (87.2) 0.11 5 (4.6) 104 (95.4) <0.05 2 (1.9) 106 (98.1) 0.26 8 (7.4) 100 (92.6) 0.75
2 partners 117 (16.9) 29 (25.7) 84 (74.3) 4 (3.5) 109 (96.5) 5 (4.3) 112 (95.7) 5 (4.3) 112 (95.7)
3–10 partners 262 (37.9) 52 (20.4) 203 (79.6) 28 (11.0) 227 (89.0) 10 (3.8) 251 (96.2) 16 (6.1) 245 (93.9)
More than 10 partners 201 (29.1) 37 (18.7) 161 (81.3) 26 (13.1) 172 (86.9) 13 (6.5) 187 (93.5) 14 (7.0) 186 (93.0)
Sexual behaviours over the past 6 months
C-IAI with men Yes 131 (18.3) 18 (14.2) 109 (85.8) 0.13 5 (3.9) 122 (96.1) <0.05 4 (3.1) 126 (96.9) 0.32 8 (6.2) 122 (93.8) 0.88
No 587 (81.7) 115 (20.0) 459 (80.0) 62 (10.8) 512 (89.2) 30 (5.2) 552 (94.8) 38 (6.5) 544 (93.5)
C-RAI sex with men Yes 469 (65.3) 97 (21.2) 360 (78.8) <0.05 49 (10.7) 408 (89.3) 0.15 23 (5.0) 441 (95.0) 0.76 30 (6.5) 434 (93.5) 0.99
No 249 (34.7) 36 (14.8) 208 (85.2) 18 (7.4) 226 (92.6) 11 (4.4) 237 (95.6) 16 (6.5) 232 (93.5)
Continued
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Statistical analysis: We tested associations between cate-
gorised variables and each of the four outcomes by
using either χ2’s test or Fisher’s exact test when needed.
Differences in the distribution of numeric variables
between subjects with and without infection were
assessed using the Wilcoxon’s Rank Sum test. Within
each sexual/gender identity group, we also assessed the
linear trend of the prevalence of each infection across
age groups using the χ2 test for linear trends. To model
the outcomes as a function of the exposure (correlate)
variables of a priori interest, we fit multivariable log-
binomial models under the Generalised Linear Models
framework using a logarithmic link and binomial family
settings.23 This approach estimates prevalence ratios
(PR), which are more appropriate for a cross-sectional
study like the present.24 Moreover, in comparison to
other alternatives, such as the Cox or Poisson regression
models, the PR obtained are less prone to errors in
interval estimation as well as less biased.25 26
The selection and inclusion of variables into the final
multivariate models relied on a conceptual framework
developed by the authors following guidelines
previously described for epidemiological applications.27
Conceptually, we considered three hierarchical levels of
variables related to the outcome: a distal level (age and
education), an intermediate level (sexual identity, sexual
role, number of partners and age at sexual debut) and a
proximal level (compensated sex and either condomless
receptive anal intercourse or oral sex—the latter accord-
ing to the outcome under analysis). Each anal infection
outcome was regressed on each variable at a time and
only one variable from each level was selected according
to its best fit measured by the lowest reported value of
Akaike Information Criterion (AIC) for the distal and
intermediate levels, or the Bayesian Information
Criterion (BIC) for the proximal level. We adopted this
approach given the specific properties of each informa-
tion criterion: AIC tends to favour the best model
among a set of candidate models while BIC tends to
favour the ‘one true model’ among a set of candidate
models.28 29 For the oral infections outcomes, we fol-
lowed the same approach, but later further limited the
number of correlates in the final model to avoid overfit-
ting and stick to the proximal and distal levels only. In
general, to avoid overfitting and instability in the final
models, we limited the number of variables to include in
the models in such a way that there are about 10 to 16
events in the outcome per dichotomous or dummy.30
We assessed potential collinearity among predictors by
measuring uncentred variance inflation factors.
RESULTS
Participants characteristics
During 2008 and 2009, we enrolled 718 participants in
Lima and surrounding areas. Participants’ age range was
18–45-years. Most of them were born in the coastal
region of Peru: 53.6% (385/718) in Lima and 32.2%
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(232/718) in other coastal cities. The remaining 14.1%
(101/718) were born in non-coastal cities. Almost 80%
of participants were concurrently working and/or study-
ing (568/718). The mean age of sexual debut was
14 years. Most participants self-reported as gay or homo-
sexual (64.8%), and having preference for a pasivo
sexual role (67.5%). The median number of sexual part-
ners in the past 6 months was 5. Further details are
described in table 1.
Infections by anatomical site, infectious agent and sexual
identity
Anal swabs were provided by 97.6% of participants
(701/718), and 99.2% (712/718) provided pharyngeal
swabs for CT and NG testing. Overall, anal infection by
CT trachomatis was 19% (95% CI 16.1% to 22.1%), while
pharyngeal infection was 4.8% (95% CI 3.3% to 6.6%).
The prevalence of NT was 9.6% (95% CI 7.5% to
12.0%) for anal infection, and 6.5% (95% CI 4.8% to
8.5%) for pharyngeal infection. This pattern of higher
CT infection in anorectum and higher NG infection in
pharynx was evident within each sexual identity sub-
group (gay/homosexual, TW and bisexual). Further
details are described in table 2.
In the anorectum, the prevalence of CT infection was
almost twice (19%) as common as for NG (9.6%); this
was true for the overall study population and within
each sexual identity group. In the oropharynx, the
prevalence of NG was slightly higher than for CT in all
cases, except for the bisexual subgroup. Comparing
across sexual identities, the prevalence of each single
and composite outcome infection was more common in
TW participants, followed by gay/homosexual, and less
common among bisexuals in most of the cases, though
these differences were not statistically significant. The
only statistically significant difference was for either pha-
ryngeal infection, p value <0.05, see table 2.
Overall, the prevalence of each of the four outcomes
of the study decreases with increasing age. The test for
trends over age group was significant (p<0.05) only in
the following cases: within gay/homosexual for anal
chlamydiasis, within gay/homosexual and TW for anal
gonorrhoea, and within transgender women for pharyn-
geal gonorrhoea. For pharyngeal chlamydiasis, a border-
line statistical significance for trend (p=0.08) was found
within TW. The graphical description of trends is shown
in figure 1.
Statistical models for outcomes and laboratory quality
assurance
The six final multivariate models are presented in
table 3. Briefly, the higher age group consistently
remained inversely associated to all single and composite
outcomes. For the oral infection outcomes, both oral
sex and compensated sex were associated with higher
proportions of infection though these were not statistic-
ally significant. For the anal infection outcomes, the
number of sexual partners showed an erratic pattern of
association and were not statistically significant in most
of the cases, while condomless receptive anal intercourse
remained directly and significantly associated with
the infections in the models where it was included. The
results of the laboratory quality assurance performed on
10% of the samples showed 100% of correlation (data
not shown).
DISCUSSION
Using a snowball-like, peer-based referral approach, we
were able to reach a group of MSM and TW at high risk
as evidenced by their high prevalence of CT and NG
infections. Using both technician-assisted pharyngeal
swabs and self-collected anal swabs, we found that close
to 25% of the study population had anal infection by
either CT or NG, while close to 10% had oropharynx
Table 2 Prevalence of anal and pharyngeal infections caused by Chlamydia trachomatis and/or Neisseria gonorrhoeae
among 718 MSM/TW participants and subgroups by self-reported sexual identity
Type of infection
Total enrolled
(N=718)
Gay/homosexual
(N=465)
Transgender
women (N=208)
Bisexual/
hetero (N=45)
p Valuen/N Per cent n/N Per cent n/N Per cent n/N Per cent
Anal
Chlamydia trachomatis 133/701 (19.0) 87/453 (19.2) 41/204 (20.1) 5/44 (11.4) 0.40
Neisseria gonorrhoeae 67/701 (9.6) 39/453 (8.6) 25/204 (12.3) 3/44 (6.8) 0.28
Either 169/701 (24.1) 105/453 (23.2) 57/204 (27.9) 7/44 (15.9) 0.18
Both concurrently 31/701 (4.4) 21/453 (4.6) 9/204 (4.4) 1/44 (2.3) 0.77
Pharyngeal
Chlamydia trachomatis 34/712 (4.8) 19/460 (4.1) 14/208 (6.7) 1/44 (2.3) 0.25
Neisseria gonorrhoeae 46/712 (6.5) 25/460 (5.4) 20/208 (9.6) 1/44 (2.3) 0.06
Either 73/712 (10.2) 41/460 (8.9) 30/208 (14.4) 2/44 (4.6) 0.04
Both concurrently 7/712 (1.0) 3/460 (0.7) 4/208 (1.9) 0/44 (0.0) 0.24
p Value from χ2 or Fisher’s exact test to compare prevalence of infections between sex identity/gender groups.
Values between parentheses are percentages in column display.
Of 718 participants, 701 provided anal swabs and 712 pharyngeal swabs.
MSM/TW, men who have sex with men transgender women.
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infection by the same bacteria. The prevalence of these
infections tends to decrease with age. Therefore, these
findings constitute a very important update in the
Peruvian scenario and become one of the few available
studies in Latin America.
Gonorrhoea prevalence in anorectal samples was
higher than previously reported in HIV and STIs
sentinel- surveillance studies conducted among MSM
and TW by the Peruvian Minister of Health during
1996–2002; this report detailed a decrease in anal NG
infection from 5.1% in 1996 to 0.2% in 2002,31 However,
their method for gonorrhoea diagnostics used the
regular culture of urethral secretion and it is very well
known that culture only detects viable bacteria in people
with active infection.32 Moreover, culturing NG from
highly-contaminated samples can be very difficult.
NAAT, especially TMA, are a more reasonable approach
for the rapid and accurate diagnosis of anal and pharyn-
geal gonorrhoea without the limitations of culture.33
However, one limitation of the NAAT technology is that
current non-active infections can result in a positive test
since the method assesses the presence of RNA and/or
DNA instead of live bacteria.34
Chlamydial infection prevalence also was quite high in
this group of MSM and TW, especially in anorectal
samples where we found the highest prevalence of infec-
tion. A previous report of Peruvian people living with
HIV who were tested for pharyngeal chlamydia infection
did not find any positive cases.35 Other studies among
MSM and young men in Peru only detected chlamydia
in urine samples.36 A previous country-level study con-
ducted among young Peruvian adults from the general
population found a prevalence of 4.2% for CT in uro-
genital samples.37 Consequently, our study adds import-
ant data to better understand the epidemiology of CT
infection in Peru.
Prevalence of chlamydia and gonorrhoea decreases
with age, and this can be explained by an increase in
the awareness of STI infections and decreases in the
number of sex partners with age.4 38 Even if not treated,
chlamydia can be cleared in certain group of infected
people.39 This inverse association between age and chla-
mydial infection has been also reported in other
studies.40 41
This is the first study in Peru that uses TMA technol-
ogy for testing CT and NG infection in extragenital sites,
and our study highlight the importance of extragenital
screening of CT and NG. Currently, the Peruvian STI
Management Guidelines19 establish that all female and
male sex workers are subject to periodic medical assess-
ment, a monthly strategy which includes STI assessment
based on a syndromic approach. If urethral discharge is
found, gonorrhoea culture must be performed and
treatment for chlamydia and gonorrhoea should be
offered. There is no further testing for chlamydial infec-
tion; and asymptomatic cases for both CT and NG infec-
tions, especially in extragenital sites, can easily be missed
and neglected. According to the current CDC recom-
mendations, NAAT testing should be available for CT
and NG diagnosis.33
There are some limitations in our analysis. The partici-
pants tested were not randomly selected and all of them
belong to high-risk groups (since they originally were
enrolled for a trial implementation) from low income
Figure 1 Trends of prevalence of anal and pharyngeal infections over age group, satisfied by agent and sexual identity.
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neighbourhoods in the metropolitan area of Lima; thus,
our results can show higher prevalences than random
MSM or TW could have, and are not necessarily general-
isable to all MSM and TW in Lima or Peru. However,
given that this is a hidden population, the ethnographic
techniques initially used to identify all of the MSM and
TW within a neighbourhood represent a nearly satu-
rated sample for each community included. At the
moment, there are no Food and Drug
Administration-cleared CT/NG tests available for non-
urogenital sites, but the CT/NG Aptima Combo-2 test
has shown good performance when used for pharyngeal
and anal samples.15 42 43
In conclusion, infection by CT and NG in extragenital
sites (anorectum and oropharynx) are very common
among MSM and TW in Lima, Peru, and both infec-
tions need to be incorporated into the regular STI
testing programmes in Peru. The overall prevalence of
CT and NG tends to decrease over age, although this
needs confirmation with further longitudinal analysis.
Screening and treatment for extragenital CT and NG at
non-healthcare facilities located in the actual venues
where this populations are by means of temporary
mobile teams is feasible through a combination of coor-
dinated work with the community, use of NAAT technol-
ogy and previous ethnographic work. These approaches
should be used by the Ministry of Health in order to
better control STIs in Lima and possibly in other cities
of Peru.
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Table 3 Multivariable models for each specific single or composite either infection by anatomic site among 718 MSM/TW
participants in Lima, Peru 2008–2009
Anatomic
site
Variables
included and
their categories
Infection
Chlamydia trachomatis Neisseria gonorrhoeae Either bacteria
PR (95% CI) PR (95% CI) PR (95% CI)
Anal C-RAI
Yes 1.4 (1.0 to 2.0) NA 1.4 (1.0 to 1.9)
No Ref NA Ref
Compensated sex
Yes NA 1.4 (0.8 to 2.5) NA
No NA Ref NA
Partners
>10 1.4 (0.8 to 2.5) 2.0 (0.7 to 5.3) 1.5 (1.0 to 2.5)
3–10 1.5 (0.9 to 2.7) 2.0 (0.8 to 5.1) 1.5 (0.9 to 2.3)
2 2.1 (1.2 to 3.7) 0.7 (0.2 to 2.6) 1.7 (1.0 to 2.8)
1 Ref Ref Ref
Age (years)
34–45 0.4 (0.3 to 0.7) 0.2 (0.1 to 0.5) 0.4 (0.2 to 0.6)
26–33 0.9 (0.6 to 1.2) 0.8 (0.5 to 1.2) 0.8 (0.6 to 1.1)
18–25 Ref Ref Ref
Pharyngeal Oral sex
Yes NA 1.3 (0.7 to 2.4) 1.3 (0.8 to 2.0)
No NA Ref Ref
Compensated sex
Yes 1.7 (0.8 to –3.4) NA NA
No Ref NA NA
Age (years)
34–45 0.3 (0.1 to –0.8) 0.3 (0.1 to 0.7) 0.3 (0.2 to 0.6)
26–33 0.7 (0.4 to –1.5) 0.7 (0.4 to 1.3) 0.7 (0.5 to 1.2)
18–25 Ref Ref Ref
Partners: Number of sexual partners reported over the past 6 months.
Oral sex: No distinction in the specific role during oral sex, just engagement over the past 6 months.
Ref: Specific subcategory used as baseline reference for the analysis.
C-RAI, condomless receptive anal intercourse; MSM/TW, men who have sex with men transgender women; NA, variable not included in the
model; PR, adjusted prevalence ratios along with 95% level CI.
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